TABLE 3.
Frequencies of neurocognitive and neuropsychiatric screening tests and measures
| Criterion frequency in all trials (N = 101) | ||
|---|---|---|
| COGNITIVE TESTS | ||
| MMSE | 91 | 90.1% |
| Memory-specific test* | 7 | 6.9% |
| RBANS | 4 | 4.0% |
| ADAS-Cog | 3 | 3.0% |
| MoCA | 1 | 1.0% |
| GLOBAL & FUNCTIONAL MEASURES | ||
| CDR | 36 | 35.6% |
| Eastern Cooperative Oncology Group status | 1 | 1.0% |
| FAQ | 1 | 1.0% |
| PSYCHIATRIC ASSESSMENTS | ||
| Geriatric Depression Scale | 25 | 24.8% |
| Hamilton Depression Rating Scale | 6 | 5.9% |
| Other depression instrument | 1 | 1.0% |
| C-SSRS | 5 | 5.0% |
| Other/unspecified suicide or self-harm risk scale | 14 | 13.9% |
Abbreviations: ADAS-Cog, Alzheimer’s Disease Assessment Scale-Cognitive Subscale; C-SSRS, Columbia Suicide Severity Rating Scale; CDR, Clinical Dementia Rating; FAQ, Functional Activities Questionnaire; MMSE, Mini-Mental State Examination; MoCA, Montreal Cognitive Assessment; RBANS, Repeatable Battery for the Assessment of Neuropsychological Status.
*
Includes Free and Cued Selective Reminding Test (FCSRT), Wechsler Memory Scale-Revised (WMS-R), and International Shopping List Test (ISLT).